(Q45731254)

15 December 2017

title

Hepatitis B virus reactivation with clinical flare in allogeneic stem cell transplants with chronic graft-versus-host disease (English)

1 reference

15 December 2017

1 reference

1 reference

Seth P

1

1 reference

15 December 2017

Alrajhi AA

2

1 reference

15 December 2017

Kagevi I

3

1 reference

15 December 2017

Chaudhary MA

4

1 reference

15 December 2017

Colcol E

5

1 reference

15 December 2017

Sahovic E

6

1 reference

15 December 2017

Aljurf M

7

1 reference

15 December 2017

Gyger M

8

1 reference

15 December 2017

language of work or name

English

0 references

publication date

1 August 2002

1 reference

Bone Marrow Transplantation

15 December 2017

published in

1 reference

15 December 2017

volume

30

1 reference

15 December 2017

issue

3

1 reference

15 December 2017

page(s)

189-194

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1703614

15 December 2017

exact match

0 references

cites work

Development of a sarcoma in a surgical scar

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703614

Hepatitis B virus persistence after recovery from acute viral hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703614

The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703614

Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703614

Latent hepatitis B virus infection in healthy individuals with antibodies to hepatitis B core antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703614

Molecular analysis of hepatitis B virus DNA in serum and peripheral blood mononuclear cells from hepatitis B surface antigen-negative cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703614

To kill or to cure: options in host defense against viral infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703614

Cytotoxic T cells and viral hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703614

Protection or damage: a dual role for the virus-specific cytotoxic T lymphocyte response in hepatitis B and C infection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703614

How can the cellular immune response control hepatitis B virus replication?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703614

Long-lasting memory T cell responses following self-limited acute hepatitis B

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703614

Recurrence of hepatitis B in children with serologic evidence of past hepatitis B virus infection undergoing antileukemic chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703614

Reactivation of hepatitis b after transplantation operations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703614

De novo and apparent de novo hepatitis B virus infection after liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703614

Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703614

Infection with Herpes Simplex Virus and Cell-Mediated Immunity after Marrow Transplant

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703614

Molecular basis for persistent hepatitis B virus infection in the liver after clearance of serum hepatitis B surface antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703614

Post-transfusion hepatitis type B following multiple transfusions of HBsAg-negative blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703614

Hepatitis B virus immunopathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703614

Hepatitis B virus DNA contains a glucocorticoid-responsive element

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703614

Corticosteroids stimulate hepatitis B virus DNA, mRNA and protein production in a stable expression system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703614

Quantitative hepatitis B virus DNA assessment by the limiting-dilution polymerase chain reaction in chronic hepatitis B patients: evidence of continuing viral suppression with longer duration and higher dose of lamivudine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703614

Lamivudine treatment for chronic replicative hepatitis B virus infection after allogeneic bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703614

Lamivudine and glycyrrhizin for treatment of chemotherapy-induced hepatitis B virus (HBV) hepatitis in a chronic HBV carrier with non-Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703614

Excess iron induces hepatic oxidative stress and transforming growth factor beta1 in genetic hemochromatosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703614

Immunobiology of allogeneic peripheral blood mononuclear cells mobilized with granulocyte-colony stimulating factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703614

Efficacy of lamivudine to prevent hepatitis reactivation in hepatitis B virus-infected patients treated for non-Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703614

Viral hepatitis, type B. Studies on natural history and prevention re-examined

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703614

7 January 2021

Hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703614

7 January 2021

Persistent viremia after recovery from self-limited acute hepatitis B

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703614

7 January 2021

Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703614

7 January 2021

Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703614

7 January 2021

Occult lifelong persistence of infectious hepadnavirus and residual liver inflammation in woodchucks convalescent from acute viral hepatitis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703614

7 January 2021

Factors affecting thymic function after allogeneic hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703614

7 January 2021

Successful treatment with lamivudine for fulminant reactivated hepatitis B infection following intensive therapy for high-grade non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703614

7 January 2021

Frequent presence of HBV in the sera of HBsAg-negative, anti-HBc-positive blood donors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703614

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1703614

1 reference

Dimensions Publication ID

15 December 2017

1003569798

0 references

1 reference